MRVI
Maravai Lifesciences Holdings Inc
7.20$
-3.0%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21.2% | 10.5% | -13.2% | 23.8% | 20.1% | -26.0% | -20.0% | -21.7% | -36.4% | -45.7% | 13.2% | 7.8% | -12.1% | |
| 19.6% | 17.5% | 21.4% | 19.8% | 21.5% | 26.9% | 31.8% | 32.5% | 38.1% | 29.5% | 19.7% | 26.1% | 27.3% | |
| 14.9% | 12.6% | 18.8% | 18.8% | 20.0% | 18.7% | 22.2% | 14.3% | 21.8% | 7.9% | 10.2% | 32.9% | 17.6% | |
| 12.8% | 3.2% | -16.6% | 3.1% | 2.9% | -22.7% | 11.7% | 2.4% | 16.8% | -39.0% | -8.8% | -1.8% | -9.2% | |
| 23.7% | 22.7% | 8.8% | 13.0% | 14.7% | 10.4% | 11.2% | 6.1% | 7.0% | 4.2% | 6.7% | 0.7% | 4.7% | |
| -23.2% | -17.4% | -6.6% | -8.4% | -13.7% | -8.7% | -49.4% | -6.8% | -7.0% | -4.2% | -6.7% | -0.7% | -4.7% | |
| – | -0.5% | -2.2% | 0.0% | 0.0% | -1.1% | – | – | 0.3% | – | – | – | – | |
| – | – | – | – | -2.3% | -406.9% | -3.3% | -3.3% | -3.7% | -1.6% | -78.0% | -180.6% | -70.2% | |
| 1.2% | 0.6% | -0.9% | 0.3% | 1.2% | -418.7% | -10.5% | -3.2% | -19.8% | -3.6% | -83.9% | -192.4% | -78.7% | |
| -0.9% | -6.3% | -20.7% | 15.6% | 7.6% | -453.4% | -79.7% | -32.0% | -63.3% | -53.5% | -77.4% | -185.3% | -95.5% | |
| -2.5% | -12.2% | -22.0% | 10.7% | 5.4% | -36.3% | -31.2% | -27.7% | -43.4% | -49.9% | 6.4% | 7.0% | -16.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.